Log in
Enquire now
‌

US Patent 11214538 Farnesoid X receptor agonists and uses thereof

Patent 11214538 was granted and assigned to Metacrine on January, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Metacrine
Metacrine
0
Current Assignee
Metacrine
Metacrine
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112145380
Patent Inventor Names
Steven P. Govek0
Johnny Y. Nagasawa0
Nicholas D. Smith0
Date of Patent
January 4, 2022
0
Patent Application Number
168729850
Date Filed
May 12, 2020
0
Patent Primary Examiner
‌
Michael G. Hartley
0
Patent abstract

Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11214538 Farnesoid X receptor agonists and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.